Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

ClinicalTrials.gov ID: NCT02556203

Public ClinicalTrials.gov record NCT02556203. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 23, 2026, 6:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Global Multicenter, Open-label, Randomized, Event-driven, Active-controlled Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement (TAVR) to Optimize Clinical Outcomes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To assess whether a rivaroxaban-based anticoagulation strategy, following successful TAVR, compared to an antiplatelet-based strategy, is superior in reducing death or first thromboembolic events (DTE). To assess the primary bleeding events (PBE) of the rivaroxaban-based strategy compared to an antiplatelet-based strategy, following TAVR.

Study identification

NCT ID: NCT02556203
Recruitment status: Terminated
Study type: Interventional
Phase: Phase 3
Lead sponsor: Bayer; Industry
Enrollment: 1,653 participants

Conditions and interventions

Conditions

Transcatheter Aortic Valve Replacement

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 16, 2015 (Actual)
Primary completion: Nov 27, 2018 (Actual)
Completion: Nov 27, 2018 (Actual)
Last update posted: Jan 13, 2020

2015 – 2018

United States locations

U.S. sites: 31
U.S. states: 20
U.S. cities: 30

Facility	City	State	ZIP	Site status
Not listed	Los Angeles	California	90048-0750	—
Not listed	Washington D.C.	District of Columbia	20010	—
Not listed	Clearwater	Florida	33756	—
Not listed	Jacksonville	Florida	32209	—
Not listed	Miami	Florida	33136	—
Not listed	Atlanta	Georgia	30322	—
Not listed	Chicago	Illinois	60611	—
Not listed	Evanston	Illinois	60201	—
Not listed	West Des Moines	Iowa	50266	—
Not listed	Baltimore	Maryland	21201	—
Not listed	Boston	Massachusetts	02215	—
Not listed	Detroit	Michigan	48202	—
Not listed	Minneapolis	Minnesota	55407	—
Not listed	Kansas City	Missouri	64111	—
Not listed	Morristown	New Jersey	07962	—
Not listed	Manhasset	New York	11030-3876	—
Not listed	New York	New York	10029	—
Not listed	Roslyn	New York	11576	—
Not listed	Winston-Salem	North Carolina	27157-1082	—
Not listed	Cincinnati	Ohio	45219	—
Not listed	Cleveland	Ohio	44195	—
Not listed	Philadelphia	Pennsylvania	19104	—
Not listed	Wilkes-Barre	Pennsylvania	18711-3752	—
Not listed	Houston	Texas	77030-1501	—
Not listed	Houston	Texas	77030	—
Not listed	Plano	Texas	75093	—
Not listed	Temple	Texas	76508	—
Not listed	Burlington	Vermont	05401	—
Not listed	Charlottesville	Virginia	22908	—
Not listed	Falls Church	Virginia	22042-3300	—
Not listed	Tacoma	Washington	98405	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 109 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02556203, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 13, 2020 · Synced Oct 23, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02556203 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →